The Vocabulary of Survival

By GEORGE BEAUREGARD From 2018 to 2022, I served as a physician executive in a large health system on Long Island. During that period, I became acquainted with the Provost and Executive VP of the New York Institute of Technology. One of the university’s divisions is the New York College of Osteopathic Medicine (NYCOM), one…

Read More

Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease

The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR gene-editing technology to inactivate the gene that codes for the protein driving this rare disease. The post Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a…

Read More

Abortion Was a Motivating Factor for Many Voters in Tuesday’s Election But Ranked Lower Than Concerns About the Economy

Abortion drove many voters to turn out for Tuesday’s election, but not always for Vice President Kamala Harris, while concerns about the economy weighed more heavily on voters’ minds, according to polling data from KFF and the Associated Press. About a quarter of voters said abortion was the “single most important” factor in their vote,…More

Read More

Impact of Medicare Part B on pharmaceutical price growth

Does Medicare Part B increase or decrease the prices of physician-administered drugs relative to physician-administered drugs covered by private insurance? That is the question a paper by Acquatella, Ericson and Starc (2023) aim to answer. Before we answer that question, we first need to understand how Part B works, how physicians are reimbursed, and how…

Read More